Caption Management LLC purchased a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 6,862 shares of the company's stock, valued at approximately $470,000.
Several other hedge funds and other institutional investors have also made changes to their positions in HSIC. UMB Bank n.a. raised its stake in Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after acquiring an additional 201 shares in the last quarter. Humankind Investments LLC increased its holdings in shares of Henry Schein by 7.4% during the fourth quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock valued at $212,000 after purchasing an additional 211 shares during the period. HB Wealth Management LLC increased its holdings in shares of Henry Schein by 1.5% during the first quarter. HB Wealth Management LLC now owns 15,419 shares of the company's stock valued at $1,056,000 after purchasing an additional 226 shares during the period. Allworth Financial LP lifted its holdings in Henry Schein by 24.5% in the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after purchasing an additional 232 shares during the period. Finally, Teachers Retirement System of The State of Kentucky lifted its holdings in Henry Schein by 2.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 9,619 shares of the company's stock worth $659,000 after purchasing an additional 238 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.
Henry Schein Price Performance
Shares of HSIC traded up $1.65 during trading hours on Friday, hitting $69.43. 1,360,668 shares of the company were exchanged, compared to its average volume of 1,569,871. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The company has a market capitalization of $8.42 billion, a PE ratio of 22.40, a PEG ratio of 2.29 and a beta of 0.86. The firm has a fifty day simple moving average of $69.92 and a 200-day simple moving average of $69.68. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same period last year, the business earned $1.23 earnings per share. The business's revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the stock. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Stifel Nicolaus restated a "hold" rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. UBS Group decreased their price target on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, August 6th. Evercore ISI raised Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective on the stock in a research note on Tuesday, August 26th. Finally, Barrington Research cut their price objective on Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a report on Wednesday, August 6th. Five equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $76.67.
View Our Latest Analysis on HSIC
Henry Schein Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.